| Identifier |
wh_ch37_p1780_1 |
| Title |
Walsh & Hoyt: Mitotane |
| Creator |
Mark L. Moster, MD; Rod Foroozan, MD |
| Affiliation |
(MLM) Thomas Jefferson University; (RF) Baylor College of Medicine |
| Subject |
Neoplasms; Neoplasms, Therapy; Chemotherapy, Adverse Effects; Radiotherapy, Adverse Effects; Bone Marrow Transplantation, Adverse Effects; Mitotane |
| Description |
Mitotane (o,p'-DDD) is a direct adrenal suppressant that is used in the treatment of inoperable adrenal cortical carcinoma. |
| Date |
2005 |
| Language |
eng |
| Format |
application/pdf |
| Type |
Text |
| Source |
Walsh and Hoyt's Clinical Neuro-Ophthalmology, 6th Edition |
| Relation is Part of |
Walsh and Hoyt's Clinical Neuro-Ophthalmology Walsh and Hoyt's Clinical Neuro-Ophthalmology |
| Collection |
Neuro-Ophthalmology Virtual Education Library: Walsh and Hoyt Textbook Selections Collection: https://NOVEL.utah.edu |
| Publisher |
Wolters Kluwer Health, Philadelphia |
| Holding Institution |
Spencer S. Eccles Health Sciences Library, University of Utah |
| Rights Management |
Copyright 2005. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright |
| ARK |
ark:/87278/s67m3hhz |
| Setname |
ehsl_novel_whts |
| ID |
186601 |
| Reference URL |
https://collections.lib.utah.edu/ark:/87278/s67m3hhz |
